4th Quarter - Report

K&L GATES, LLP for NEUROTECHNOLOGY INDUSTRY ORGANIZATION

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Advocate for HR 5989 and S 2989, the National Neurotechnology Initiative Act, all provisions.

LobbyistCovered position, as disclosed
AMY CARNEVALE —
DENISE GITSHAM —
SLADE GORTON —
DANIEL RITTER —
CHAD SEE —
W DENNIS STEPHENS —
PAUL STIMERS —
STEVEN RICHARDS VALENTINE —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5989 (110th)

Health Issues HCR

Advocate for HR 5989 and S 2989, the National Neurotechnology Initiative Act, all provisions.

LobbyistCovered position, as disclosed
AMY CARNEVALE —
DENISE GITSHAM —
SLADE GORTON —
DANIEL RITTER —
CHAD SEE —
W DENNIS STEPHENS —
PAUL STIMERS —
STEVEN RICHARDS VALENTINE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 5989 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.